Recent Clinical Trials Shed New Light on the Cardiovascular Benefits of Omega-3 Fatty Acids
References
- Kris-Etherton PM Harris WS Appel LJ American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease Circulation 2002 Nov 19 106 21 2747 57
- Siscovick DS Barringer TA Fretts AM American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association Circulation 2017 Apr 11 135 15 e867 e884
- Bowen KJ Harris WS Kris-Etherton PM Omega-3 Fatty Acids and Cardiovascular Disease: Are There Benefits? Curr Treat Options Cardiovasc Med. 2016 Nov 18 11 69
- Manson JE Cook NR Lee IM VITAL Research Group Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer N Engl J Med 2019 Jan 3 380 1 23 32
- Bowman L Mafham M Wallendszus K ASCEND Study Collaborative Group Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus N Engl J Med 2018 Oct 18 379 16 1540 1550
- Bhatt DL Steg PG Miller M REDUCE-IT Investigators Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia N Engl J Med 2019 Jan 3 380 1 11 22
- Bowman L Mafham M Wallendszus K ASCEND Study Collaborative Group Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus N Engl J Med 2018 Oct 18 379 16 1529 39
- Alexander DD Miller PE Van Elswyk ME Kuratko CN Bylsma LC A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk Mayo Clin Proc 2017 Jan 92 1 15 29
- Maki KC Palacios OM Bell M Toth PP Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps J Clin Lipidol. 2017 Sep - Oct 11 5 1152 1160.e2
- Sabatine MS Giugliano RP Keech AC FOURIER Steering Committee and Investigators Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease N Engl J Med 2017 May 4 376 18 1713 22
- Szarek M White HD Schwartz GG ODYSSEY OUTCOMES Committees and Investigators Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial J Am Coll Cardiol 2019 Feb 5 73 4 387 96
- Cannon CP Blazing MA Giugliano RP IMPROVE-IT Investigators Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes N Engl J Med 2015 Jun 18 372 25 2387 97
- Boden WE Probstfield JL Anderson T AIM-HIGH Investigators Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N Engl J Med 2011 Dec 15 365 24 2255 67
- Barter PJ Caulfield M Eriksson M ILLUMINATE Investigators Effects of torcetrapib in patients at high risk for coronary events N Engl J Med 2007 Nov 22 357 21 2109 22
- Bowman L Hopewell JC Chen F HPS3/TIMI55–REVEAL Collaborative Group Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease N Engl J Med 2017 Sep 28 377 13 1217 1227
- Lincoff AM Nicholls SJ Riesmeyer JS ACCELERATE Investigators Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease N Engl J Med 2017 May 18 376 20 1933 1942
- Curfman G The unfulfilled promise of omega-3 fatty acid supplementation JAMA Intern Med 2017 Feb 1 177 2 194
- Nicholls SJ Lincoff AM Bash D Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial Clin Cardiol 2018 Oct 41 10 1281 1288
- Burr ML Fehily AM Gilbert JF Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART) Lancet 1989 Sep 30 2 8666 757 61
- Burr ML Sweetnam PM Fehily AM Diet and reinfarction Eur Heart J 1994 Aug 15 8 1152 3
- Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto miocardico Lancet 1999 Aug 7 354 9177 447 55
- Yokoyama M Origasa H Matsuzaki M Japan EPA lipid intervention study (JELIS) Investigators Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis Lancet 2007 Mar 31 369 9567 1090 8
- Tavazzi L Maggioni AP Marchioli R GISSI-HF Investigators Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet 2008 Oct 4 372 9645 1223 30
- Kromhout D Giltay EJ Geleijnse JM Alpha Omega Trial Group N-3 fatty acids and cardiovascular events after myocardial infarction N Engl J Med 2010 Nov 18 363 21 2015 26
- Rauch B Schiele R Schneider S OMEGA Study Group OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction Circulation 2010 Nov 23 122 21 2152 9
- Galan P Kesse-Guyot E Czernichow S Briancon S Blacher J Hercberg S SU.FOL.OM3 Collaborative Group Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial BMJ 2010 Nov 29 341 c6273
- ORIGIN Trial Investigators Bosch J Gerstein HC n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia N Engl J Med 2012 Jul 26 367 4 309 18
- Risk and Prevention Study Collaborative Group Roncaglioni MC Tombesi M n-3 fatty acids in patients with multiple cardiovascular risk factors N Engl J Med 2013 May 9 368 19 1800 8
- Rischio and Prevenzione Investigators Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: Rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice Trials 2010 May 28 11 68
- Writing Group for the AREDS2 Research Group Bonds DE Harrington M Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial JAMA Intern Med 2014 May 174 5 763 71
- Jacobson TA Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease Am J Clin Nutr 2008 Jun 87 6 1981S 90S
- Skulas-Ray AC West SG Davidson MH Kris-Etherton PM Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia Expert Opin Pharmacother 2008 May 9 7 1237 48
- Davidson MH Stein EA Bays HE COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study Clin Ther 2007 Jul 29 7 1354 67
- Ballantyne CM Bays HE Kastelein JJ Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study) Am J Cardiol 2012 Oct 1 110 7 984 92
- Oh PC Koh KK Sakuma I Omega-3 fatty acid therapy dose-dependently and significantly decreased triglycerides and improved flow-mediated dilation, however, did not significantly improve insulin sensitivity in patients with hypertriglyceridemia Int J Cardiol 2014 Oct 20 176 3 696 702
- Maki KC Orloff DG Nicholls SJ A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial) Clin Ther 2013 Sep 35 9 1400 11.e1-3
- Skulas-Ray AC Kris-Etherton PM Harris WS Vanden Heuvel JP Wagner PR West SG Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia Am J Clin Nutr 2011 Feb 93 2 243 52
- Mozaffarian D Wu JH (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? J Nutr. 2012 Mar 142 3 614S 625S
- Calder PC Omega-3 fatty acids and inflammatory processes: from molecules to man Biochem Soc Trans 2017 Oct 15 45 5 1105 1115
-
Rosenthal
MD
Patel
J
Staton
K
Martindale
RG
Moore
FA
Upchurch
GR
Jr. Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil? Curr Gastroenterol Rep. 2018 Aug 4 20 9 40 - Endo J Sano M Isobe Y 18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling J Exp Med 2014 Jul 28 211 8 1673 87
- Richter CK Skulas-Ray AC Kris-Etherton P Recommended intake of fish and fish oils worldwide In Raatz S Bibus DM editors Fish and fish oils in health and disease San Diego Academic Press 2016 p 27 48
- Thompson M Hein N Hanson C Omega-3 Fatty Acid Intake by Age, Gender, and Pregnancy Status in the United States: National Health and Nutrition Examination Survey 2003–2014 Nutrients 2019 Jan 15 11 1
- Richter CK Bowen KJ Mozaffarian D Kris-Etherton PM Skulas-Ray AC Total Long-Chain n-3 Fatty Acid Intake and Food Sources in the United States Compared to Recommended Intakes: NHANES 2003–2008 Lipids 2017 Nov 52 11 917 927
- Jackson KH Polreis JM Tintle NL Kris-Etherton PM Harris WS Association of reported fish intake and supplementation status with the omega-3 index Prostaglandins Leukot Essent Fatty Acids 2019 Mar 142 4 10
- Harris WS Von Schacky C The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med. 2004 Jul 39 1 212 20
- Del Gobbo LC Imamura F Aslibekyan S Omega-3 polyunsaturated fatty acid biomarkers and coronary heart disease: Pooling project of 19 cohort studies JAMA Intern Med 2016 Aug 1 176 8 1155 66
- Harris WS Tintle NL Etherton MR Vasan RS Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart Study J Clin Lipidol. 2018 May - Jun 12 3 718 727.e6
- Rimm EB Appel LJ Chiuve SE American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: A Science Advisory From the American Heart Association Circulation 2018 Jul 3 138 1 e35 e47
DOI: https://doi.org/10.14797/mdcj-15-3-171 | Journal eISSN: 1947-6108
Language: English
Page range: 171 - 178
Published on: Jul 1, 2019
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2019 Penny M. Kris-Etherton, Chesney K. Richter, Kate J. Bowen, Ann C. Skulas-Ray, Kristina Harris Jackson, Kristina S. Petersen, William S. Harris, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.